Search Results | Scholarly Articles, Journals, and E-Books

Results: 39

Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 446, doi. 10.1038/sj.leu.2404501
By:
- Esteve, J.;
- Escoda, L.;
- Martín, G.;
- Rubio, V.;
- Díaz-Mediavilla, J.;
- González, M.;
- Rivas, C.;
- Álvarez, C.;
- González San Miguel, J. D.;
- Brunet, S.;
- Tomás, J. F.;
- Tormo, M.;
- Sayas, M. J.;
- Sánchez Godoy, P.;
- Colomer, D.;
- Bolufer, P.;
- Sanz, M. A.
Publication type:
Article
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 578, doi. 10.1038/sj.leu.2404504
By:
- Potenza, L.;
- Barozzi, P.;
- Vallerini, D.;
- Bosco, R.;
- Quadrelli, C.;
- Mediani, L.;
- Morselli, M.;
- Forghieri, F.;
- Volzone, F.;
- Codeluppi, M.;
- Rossi, G.;
- Tazzioli, G.;
- Venturelli, C.;
- Torelli, G.;
- Luppi, M.
Publication type:
Article
Levels of soluble HLA-I and β2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 480, doi. 10.1038/sj.leu.2404506
By:
- Albitar, M.;
- Johnson, M.;
- Do, K. A.;
- Day, A.;
- Jilani, I.;
- Pierce, S.;
- Estey, E.;
- Kantarjian, H.;
- Keating, M.;
- Verstovsek, S.;
- O'Brien, S.;
- Giles, F. J.
Publication type:
Article
Deletion of 11q23 is a highly specific nonrandom secondary genetic abnormality of ETV6/RUNX1-rearranged childhood acute lymphoblastic leukemia.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 584, doi. 10.1038/sj.leu.2404507
By:
- Attarbaschi, A.;
- Mann, G.;
- Strehl, S.;
- König, M.;
- Steiner, M.;
- Jeitler, V.;
- Lion, Th.;
- Dworzak, M. N.;
- Gadner, H.;
- Haas, O. A.
Publication type:
Article
Antitumor activity of sorafenib in FLT3-driven leukemic cells.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 439, doi. 10.1038/sj.leu.2404508
By:
- Auclair, D.;
- Miller, D.;
- Yatsula, V.;
- Pickett, W.;
- Carter, C.;
- Chang, Y.;
- Zhang, X.;
- Wilkie, D.;
- Burd, A.;
- Shi, H.;
- Rocks, S.;
- Gedrich, R.;
- Abriola, L.;
- Vasavada, H.;
- Lynch, M.;
- Dumas, J.;
- Trail, P. A.;
- Wilhelm, S. M.
Publication type:
Article
Reply to ‘Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML’ by Summers et al.
Published in:
2007
By:
- Nyvold, C. G.;
- Ommen, H. B.;
- Østergaard, M.;
- Hokland, P.
Publication type:
Letter
Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe—Impact of cost considerations.
Published in:
2007
By:
- Gratwohl, A.;
- Baldomero, H.;
- Schwendener, A.;
- Gratwohl, M.;
- Urbano-Ispizua, A.;
- Frauendorfer, K.
Publication type:
Editorial
Sequence-dependent synergy of the proteasome inhibitor bortezomib and cytarabine in mantle cell lymphoma.
Published in:
2007
By:
- Weigert, O.;
- Pastore, A.;
- Rieken, M.;
- Lang, N.;
- Hiddemann, W.;
- Dreyling, M.
Publication type:
journal article
Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 511, doi. 10.1038/sj.leu.2404512
By:
- Karlsson, C.;
- Hansson, L.;
- Celsing, F.;
- Lundin, J.
Publication type:
Article
Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders.
Published in:
2007
By:
- Jost, E.;
- do Ó, N.;
- Dahl, E.;
- Maintz, C. E.;
- Jousten, P.;
- Habets, L.;
- Wilop, S.;
- Herman, J. G.;
- Osieka, R.;
- Galm, O.;
- do O, N
Publication type:
journal article
Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML.
Published in:
2007
By:
- Summers, K.;
- Stevens, J.;
- Kakkas, I.;
- Smith, M.;
- Smith, L. L.;
- MacDougall, F.;
- Cavenagh, J.;
- Bonnet, D.;
- Young, B. D.;
- Lister, T. A.;
- Fitzgibbon, J.
Publication type:
commentary
FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells.
Published in:
2007
By:
- Crescenzi, B.;
- Chase, A.;
- La Starza, R.;
- Beacci, D.;
- Rosti, V.;
- Gallì, A.;
- Specchia, G.;
- Martelli, M. F.;
- Vandenberghe, P.;
- Cools, J.;
- Jones, A. V.;
- Cross, N. C. P.;
- Marynen, P.;
- Mecucci, C.;
- Starza, R La;
- Gallì, A
Publication type:
journal article
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 529, doi. 10.1038/sj.leu.2404516
By:
- Stewart, A. K.;
- Bergsagel, P. L.;
- Greipp, P. R.;
- Dispenzieri, A.;
- Gertz, M. A.;
- Hayman, S. R.;
- Kumar, S.;
- Lacy, M. Q.;
- Lust, J. A.;
- Russell, S. J.;
- Witzig, T. E.;
- Zeldenrust, S. R.;
- Dingli, D.;
- Reeder, C. B.;
- Roy, V.;
- Kyle, R. A.;
- Rajkumar, S. V.;
- Fonseca, R.
Publication type:
Article
The pathogenesis of MALT lymphomas: where do we stand?
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 389, doi. 10.1038/sj.leu.2404517
By:
- Sagaert, X.;
- De Wolf-Peeters, C.;
- Noels, H.;
- Baens, M.
Publication type:
Article
Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 541, doi. 10.1038/sj.leu.2404520
By:
- Gutiérrez, N. C.;
- Ocio, E. M.;
- de las Rivas, J.;
- Maiso, P.;
- Delgado, M.;
- Fermiñ&;#x00E1;n, E.;
- Arcos, M. J.;
- Sánchez, M. L.;
- Hernández, J. M.;
- San Miguel, J. F.
Publication type:
Article
Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 453, doi. 10.1038/sj.leu.2404521
By:
- Thomas, X.;
- Raffoux, E.;
- Botton, S. de;
- Pautas, C.;
- Arnaud, P.;
- de Revel, T.;
- Reman, O.;
- Terré, C.;
- Corront, B.;
- Gardin, C.;
- Le, Q.-H.;
- Quesnel, B.;
- Cordonnier, C.;
- Bourhis, J.-H.;
- Elhamri, M.;
- Fenaux, P.;
- Preudhomme, C.;
- Michallet, M.;
- Castaigne, S.;
- Dombret, H.
Publication type:
Article
Increased frequencies of CD4+CD25high Tregs correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 472, doi. 10.1038/sj.leu.2404522
By:
- Nadal, E.;
- Garin, M.;
- Kaeda, J.;
- Apperley, J.;
- Lechler, R.;
- Dazzi, F.
Publication type:
Article
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts.
Published in:
2007
By:
- Tazzari, P. L.;
- Cappellini, A.;
- Ricci, F.;
- Evangelisti, C.;
- Papa, V.;
- Grafone, T.;
- Martinelli, G.;
- Conte, R.;
- Cocco, L.;
- McCubrey, J. A.;
- Martelli, A. M.
Publication type:
journal article
Clinical significance of TP53 mutation in myeloma.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 582, doi. 10.1038/sj.leu.2404524
By:
- Chng, W. J.;
- Price-Troska, T.;
- Gonzalez-Paz, N.;
- Van Wier, S.;
- Jacobus, S.;
- Blood, E.;
- Henderson, K.;
- Oken, M.;
- Van Ness, B.;
- Greipp, P.;
- Rajkumar, S. V.;
- Fonseca, R.
Publication type:
Article
Treatment of deletion 5q acute myeloid leukemia with lenalidomide.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 586, doi. 10.1038/sj.leu.2404526
By:
- Lancet, J. E.;
- List, A. F.;
- Moscinski, L. C.
Publication type:
Article
JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults.
Published in:
2007
By:
- Kiyoi, H.;
- Yamaji, S.;
- Kojima, S.;
- Naoe, T.
Publication type:
research
Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
Published in:
2007
By:
- Bertrand, P.;
- Bastard, C.;
- Maingonnat, C.;
- Jardin, F.;
- Maisonneuve, C.;
- Courel, M.-N.;
- Ruminy, P.;
- Picquenot, J.-M.;
- Tilly, H.
Publication type:
journal article
Different target range and cytotoxic specificity of adaphostin and 17-allylamino-17-demethoxygeldanamycin in imatinib-resistant and sensitive cell lines.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 421, doi. 10.1038/sj.leu.2404533
By:
- Barnes, D. J.;
- De, S.;
- van Hensbergen, P.;
- Moravcsik, È;
- Melo, J. V.
Publication type:
Article
Do affluent societies have the only options for the best therapy?
Published in:
2007
By:
- Gajewski, J. L.;
- Robinson, P.
Publication type:
Editorial
Thymidine kinase 1 – A prognostic and diagnostic indicator in ALL and AML patients.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 560, doi. 10.1038/sj.leu.2404536
By:
- O'Neill, K. L.;
- Zhang, F.;
- Li, H.;
- Fuja, D. G.;
- Murray, B. K.
Publication type:
Article
Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 556, doi. 10.1038/sj.leu.2404537
By:
- Yoshimi, A.;
- Mohamed, M.;
- Bierings, M.;
- Urban, C.;
- Korthof, E.;
- Zecca, M.;
- Sykora, K.-W.;
- Duffner, U.;
- Trebo, M.;
- Matthes-Martin, S.;
- Sedlacek, P.;
- Klingebiel, T.;
- Lang, P.;
- Führer, M.;
- Claviez, A.;
- Wössmann, W.;
- Pession, A.;
- Arvidson, J.;
- O'Marcaigh, A. S.;
- van den Heuvel-Eibrink, M. M.
Publication type:
Article
Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia.
Published in:
2007
By:
- Meyer, C.;
- Burmeister, T.;
- Strehl, S.;
- Schneider, B.;
- Hubert, D.;
- Zach, O.;
- Haas, O.;
- Klingebiel, T.;
- Dingermann, T.;
- Marschalek, R.
Publication type:
Letter
Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemia.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 571, doi. 10.1038/sj.leu.2404543
By:
- Tyybäkinoja, A.;
- Elonen, E.;
- Piippo, K.;
- Porkka, K.;
- Knuutila, S.
Publication type:
Article
NOTCH1-induced T-cell leukemia in transgenic zebrafish.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 462, doi. 10.1038/sj.leu.2404546
By:
- Chen, J.;
- Jette, C.;
- Kanki, J. P.;
- Aster, J. C.;
- Look, A. T.;
- Griffin, J. D.
Publication type:
Article
Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 403, doi. 10.1038/sj.leu.2404547
By:
- Okamoto, M.;
- Hayakawa, F.;
- Miyata, Y.;
- Watamoto, K.;
- Emi, N.;
- Abe, A.;
- Kiyoi, H.;
- Towatari, M.;
- Naoe, T.
Publication type:
Article
Leukemia targeting ligands isolated from phage display peptide libraries.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 411, doi. 10.1038/sj.leu.2404548
By:
- Jäger, S.;
- Jahnke, A.;
- Wilmes, T.;
- Adebahr, S.;
- Vögtle, F.-N.;
- deLima-Hahn, E.;
- Pfeifer, D.;
- Berg, T.;
- Lübbert, M.;
- Trepel, M.
Publication type:
Article
Molecular signature of CD34+ hematopoietic stem and progenitor cells of patients with CML in chronic phase.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 494, doi. 10.1038/sj.leu.2404549
By:
- Diaz-Blanco, E.;
- Bruns, I.;
- Neumann, F.;
- Fischer, J. C.;
- Graef, T.;
- Rosskopf, M.;
- Brors, B.;
- Pechtel, S.;
- Bork, S.;
- Koch, A.;
- Baer, A.;
- Rohr, U.-P.;
- Kobbe, G.;
- von Haeseler, A.;
- Gattermann, N.;
- Haas, R.;
- Kronenwett, R.
Publication type:
Article
Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 568, doi. 10.1038/sj.leu.2404550
By:
- Fouillard, L.;
- Chapel, A.;
- Bories, D.;
- Bouchet, S.;
- Costa, J.-M.;
- Rouard, H.;
- Hervé, P.;
- Gourmelon, P.;
- Thierry, D.;
- Lopez, M.;
- Gorin, N. C.
Publication type:
Article
Myelofibrosis with a novel translocation, t(1;3)(q31;q23), and response to imatinib mesylate.
Published in:
2007
By:
- Yalamanchili, K.;
- Liu, D.;
- Seiter, K.
Publication type:
Case Study
Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 489, doi. 10.1038/sj.leu.2404554
By:
- Sherbenou, D. W.;
- Wong, M. J.;
- Humayun, A.;
- McGreevey, L. S.;
- Harrell, P.;
- Yang, R.;
- Mauro, M.;
- Heinrich, M. C.;
- Press, R. D.;
- Druker, B. J.;
- Deininger, M. W.
Publication type:
Article
Phosphoproteomic analysis identifies the M0-91 cell line as a cellular model for the study of TEL-TRKC fusion-associated leukemia.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 563, doi. 10.1038/sj.leu.2404555
By:
- Gu, T.-L.;
- Popova, L.;
- Reeves, C.;
- Nardone, J.;
- MacNeill, J.;
- Rush, J.;
- Nimer, S. D.;
- Polakiewicz, R. D.
Publication type:
Article
CD200 as a prognostic factor in acute myeloid leukaemia.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 566, doi. 10.1038/sj.leu.2404559
By:
- Tonks, A.;
- Hills, R.;
- White, P.;
- Rosie, B.;
- Mills, K. I.;
- Burnett, A. K.;
- Darley, R. L.
Publication type:
Article
Risk factors of central venous lines-related thrombosis in children with acute lymphoblastic leukemia during induction therapy: a prospective study.
Published in:
2007
By:
- Farinasso, L.;
- Bertorello, N.;
- Garbarini, L.;
- Gajno, T. M.;
- Barisone, E.;
- Artesani, L.;
- Valori, A.;
- Giacchino, M.;
- Pastore, G.;
- Saracco, P.
Publication type:
Letter
Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of β-catenin/TCF pathway.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 535, doi. 10.1038/sj.leu.2404561
By:
- Yasui, H.;
- Hideshima, T.;
- Ikeda, H.;
- Ocio, E. M.;
- Kiziltepe, T.;
- Vallet, S.;
- Okawa, Y.;
- Neri, P.;
- Sukhdeo, K.;
- Podar, K.;
- Chauhan, D.;
- Richardson, P. G.;
- Raje, N.;
- Carrasco, D. R.;
- Anderson, K. C.
Publication type:
Article

Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.

Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates.

Levels of soluble HLA-I and β2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy.

Deletion of 11q23 is a highly specific nonrandom secondary genetic abnormality of ETV6/RUNX1-rearranged childhood acute lymphoblastic leukemia.

Antitumor activity of sorafenib in FLT3-driven leukemic cells.

Reply to ‘Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML’ by Summers et al.

Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe—Impact of cost considerations.

Sequence-dependent synergy of the proteasome inhibitor bortezomib and cytarabine in mantle cell lymphoma.

Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).

Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders.

Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML.

FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells.

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.

The pathogenesis of MALT lymphomas: where do we stand?

Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.

Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.

Increased frequencies of CD4<sup>+</sup>CD25<sup>high</sup> T<sub>regs</sub> correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia.

Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts.

Clinical significance of TP53 mutation in myeloma.

Treatment of deletion 5q acute myeloid leukemia with lenalidomide.

JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults.

Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.

Different target range and cytotoxic specificity of adaphostin and 17-allylamino-17-demethoxygeldanamycin in imatinib-resistant and sensitive cell lines.

Do affluent societies have the only options for the best therapy?

Thymidine kinase 1 – A prognostic and diagnostic indicator in ALL and AML patients.

Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia.

Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia.

Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemia.

NOTCH1-induced T-cell leukemia in transgenic zebrafish.

Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD.

Leukemia targeting ligands isolated from phage display peptide libraries.

Molecular signature of CD34<sup>+</sup> hematopoietic stem and progenitor cells of patients with CML in chronic phase.

Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation.

Myelofibrosis with a novel translocation, t(1;3)(q31;q23), and response to imatinib mesylate.

Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib.

Phosphoproteomic analysis identifies the M0-91 cell line as a cellular model for the study of TEL-TRKC fusion-associated leukemia.

CD200 as a prognostic factor in acute myeloid leukaemia.

Risk factors of central venous lines-related thrombosis in children with acute lymphoblastic leukemia during induction therapy: a prospective study.

Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of β-catenin/TCF pathway.